Suraksha Diagnostic Ltd
Suraksha Diagnostic Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹99Cr
- Net profit
- ₹15Cr
- Margin
- 35.1%
Suraksha Diagnostic Ltd Q2 FY27 key numbers
- Revenue
- Q2 FY27 Total Income: ₹1,005.75 million, up 26% year-on-year.
As stated in Suraksha Diagnostic Ltd's Q2 FY27 results statement · published 10 Nov 2026. Reported figures, not investment advice.
Based on Suraksha Diagnostic Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Q2 FY27 Total Income: ₹1,005.75 million, up 26% year-on-year. Q2 FY27 EBITDA: ₹363.17 million, up 45% year-on-year.
From Suraksha Diagnostic Ltd's Q2 FY27 earnings-call transcript · updated 10 Nov 2026.
How did Suraksha Diagnostic's revenue grow in the September 2026 quarter?
2 more points from Suraksha Diagnostic Ltd's call on revenue
Create a free account to keep reading this call
What happened to Suraksha Diagnostic's margins in Q2 FY27?
See what Suraksha Diagnostic Ltd said on profitability & margins — free account, 30 seconds.
What capex is Suraksha Diagnostic planning?
- Suraksha Diagnostic Limited opened five new centres in Q2 FY27: two hub centres and three spoke centres, expanding their network per cluster-building strategy.
- This expansion strengthens presence in West Bengal and prepares for entry into newer markets.
- The newly commissioned centres from prior quarters are maturing and starting to contribute to growth.
- The company focuses on disciplined expansion in existing and new markets, aiming for sustainable growth through network and maturing centres.
Is Suraksha Diagnostic raising money or cutting debt?
See what Suraksha Diagnostic Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Suraksha Diagnostic's order book?
See what Suraksha Diagnostic Ltd said on order book & pipeline — free account, 30 seconds.
Suraksha Diagnostic Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the table below.
Suraksha Diagnostic Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 99 |
| Operating profit (EBITDA) | 35 |
| Operating margin | 35.1% |
| Profit before tax | 19 |
| Net profit (PAT) | 15 |
| EPS (₹) | 2.88 |
Source: Suraksha Diagnostic Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹88 Cr, net profit ₹13 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Suraksha Diagnostic's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call analysis →
Earlier calls (2)
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Suraksha Diagnostic Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Suraksha Diagnostic Ltd Q2 FY27 results?
Q2 FY27 Total Income: ₹1,005.75 million, up 26% year-on-year. Q2 FY27 EBITDA: ₹363.17 million, up 45% year-on-year.
What is Suraksha Diagnostic Ltd share price analysis?
Suraksha Diagnostic Ltd currently shows a neutral. The stock trades at a P/E of 50.7 with a market cap of ₹1,815 Cr. Investors should review the full earnings analysis for detailed insights.
Is Suraksha Diagnostic Ltd planning capital expenditure?
Suraksha Diagnostic Limited opened five new centres in Q2 FY27: two hub centres and three spoke centres, expanding their network per cluster-building strategy.
Keep Suraksha Diagnostic Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.